GRI Bio, Inc. (GRI) vs Nuvilex Inc. (PMCB)
GRI Bio, Inc. and Nuvilex Inc. are both Biotechnology companies. GRI Bio, Inc. and Nuvilex Inc. are of similar size ($4.9M and $4.6M). Nuvilex Inc. has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. Across the 10 metrics below, Nuvilex Inc. leads on 6 and GRI Bio, Inc. on 4.
Valuation
Profitability
| Metric | GRI | PMCB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 95.64% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (142.02%) | (58.04%) | (57.72%) |
| Return on assets | (113.27%) | (50.43%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack